Gavilimomab
CAS No. 244096-20-6
Gavilimomab
4-(1-METHYL-1-PHENYL-ETHYL)-ANISOLE
6623-93-4
1H-Imidazole,1-(4-ethylphenyl)-4,5-diethynyl-
706785-18-4
1,2,3-Triazine, 4,5,6-trichloro-
70674-51-0
1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2-THIOL
66234-79-5
7,10-Methanopyrido[1,2-a]azepine,decahydro-
90307-52-1
1-Butanol, 2-amino-4-(1-naphthalenyloxy)-
66233-15-6
1,4-Butanediamine, dinitrate
70677-59-7
1-Heptanol, 1-(trimethylsilyl)-
66235-29-8
1-Hexanol, 1-(trimethylsilyl)-
66235-28-7
1-Dodecanamine, 4-methylbenzenesulfonate
66237-10-3
Phenol, dichloromethyl-
70679-67-3
Cyclohexane, 1-(ethenyloxy)-2-methylene-
70679-16-2
Cyclopropenylium, tri-1-pyrrolidinyl-, azide
70674-31-6
Benzaldehyde, 3-cyclohexyl-2-hydroxy-
66232-33-5
Thietane, 2-propyl-
70678-49-8
Undecanoic acid, 2-butyl-
66241-54-1
cyclopentyl 3-oxobutanoate
6624-83-5
6,9-Methanopyrrolo[1,2-a]azocine,decahydro-
90307-51-0
4-methylcyclohexyl 2-oxopropanoate
6624-85-7
1H-Imidazole,1-methyl-4,5-di-1-propyn-1-yl-
706785-34-4
1H-Indole-2-methanol,3,5-dimethyl-
706788-98-9
α,2,3,6-Tetramethylbenzene-1-propanol
66248-70-2
2-[14-(oxiran-2-yl)tetradecyl]oxirane
6624-26-6